Michelle Mello

Michelle Mello Stanford

Michelle Mello, JD, PhD

  • Professor, Health Policy
  • Professor, Law
(650) 725-3894 (voice)

Biography

Michelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine.  She conducts empirical research into issues at the intersection of law, ethics, and health policy.  She is the author of more than 230 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, health information privacy, and other topics.
 
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40.  From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
 
Dr. Mello teaches courses in torts, public health law, and health policy.  She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. 

In The News

Illustration of scary AI in health care
Commentary

Regulation of Health and Health Care Artificial Intelligence

In this JAMA Viewpoint, SHP's Michelle Mello discusses the paucity of formal regulations dealing with artificial intelligence in health care and what may lie ahead.
Regulation of Health and Health Care Artificial Intelligence
A sign for a County Health Department
Commentary

The Hard Road Ahead for Public Health Departments

Public health officials—already on the defensive due to the backlash against COVID-19 pandemic orders—are now facing a lack of support from the federal government, leaving them alone on the front lines to promote health while battling disease.
The Hard Road Ahead for Public Health Departments
AI Diagnostic Tool-Illustration
Commentary

How AI Diagnostic Tools Can Lead to Financial Burdens for Patients

According to the co-authors of a perspective published in the New England Journal of Medicine, the use of AI diagnostic tools by medical practitioners can lead to unexpected financial burdens for their patients.
How AI Diagnostic Tools Can Lead to Financial Burdens for Patients